A Randomized Phase II Study of Androgen Deprivation Therapy With or Without PD 0332991 in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2018
At a glance
- Drugs Palbociclib (Primary) ; Bicalutamide; Goserelin; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Feb 2018 Results of a biomarker analysis, presented at the 2018 Genitourinary Cancers Symposium.
- 10 Jun 2017 Biomarkers information updated
- 02 May 2017 Status changed from recruiting to active, no longer recruiting.